Alzheimer’s Society UK Dementia Trials Network Research Nurse - JOB DESCRIPTION

Reporting to:

Alzheimer’s Society UKDTN Lead Research Nurse

Working hours:

Full-time, 37.5 hours. Monday – Friday, 9.00am-5.00pm

Salary scale:

£40,950 to £46,725

Contract length:

Fixed funding for 3 years

Required qualifications

A current registered adult or mental health nurse on the Register of the Nursing and Midwifery Council (NMC)

JOB SUMMARY:

To expand and enable access to early phase dementia and mild cognitive impairment clinical research studies.

Role Purpose

In this role, you’ll be part of a supportive, multidisciplinary team driving forward expansion of early phase dementia and neurodegenerative clinical research. You’ll help deliver a range of early phase trials and play an active role in reaching and engaging underserved communities, raising awareness and making sure everyone has the opportunity to take part in high quality research where available and appropriate to their care.

This role is funded by the UK Dementia Trials Network, supported as part of the Alzheimer's Society UKDTN Research Nurse programme, and hosted by ReMind UK.

At ReMind UK, our research helps improve the lives of people affected by neurodegenerative conditions such as Alzheimer’s disease. We’re looking for someone who is proactive, collaborative and flexible — someone who enjoys working with others and is excited to contribute to the newly established UK Dementia Trials Network and Alzheimer’s Society UKDTN Research Nurse programme.

Together, we’ll continue to push for progress, share expertise and make a real difference for the people and families we support.

ReMind UK

ReMind UK is an independent charity and internationally respected centre leading the way in dementia research, diagnosis and care. From our home in Bath, we combine worldclass clinical

ReMind UK, The Research Institute for Brain Health, Royal United Hospital, Combe Park, Bath BA1 3NG Reception +44 (0) 1225 476 420 · www.reminduk.org · info@reminduk.org

and academic expertise with compassionate, person centred support for people affected by dementia and other conditions of older age.

Every day, we’re working to get ahead of dementia — delivering cutting edge research, providing expert memory assessment and diagnosis, and offering trusted information, courses and support for individuals, families and carers.

We partner closely with universities, the NHS and international research bodies to explore new treatments and better ways of living well with dementia. As we grow, we’re expanding our research programmes and strengthening our impact across the region and beyond.

At ReMind, our values shape how we show up:

• We’re Progressive — always learning, improving and driving change.

• We’re Expert — evidence led, confident and committed to excellence.

• We’re Empathetic — treating people as individuals with dignity and understanding.

We’re Collaborative — working together, with colleagues and partners, to make a meaningful difference.

Together, we’re creating a future where earlier intervention, better treatments and stronger support help people live well for longer.

UK Dementia Trials Network

ReMind UK is a Member Site of the UKDTN which was established in 2024 with just under £50 million of NIHR funding to build capacity, capability and expertise in early phase dementia trial delivery across all four nations of the UK. Led by Professor Cath Mummery, the UKDTN will work with a range of stakeholders to establish 20 sustainable early phase dementia clinical trial sites across the UK over five years.

The UKDTN will work closely with industry partners, people affected by dementia and the wider dementia and neurodegeneration ecosystem to:

Enable more people living with dementia or mild cognitive impairment to have an opportunity to take part in an early phase dementia clinical trial irrespective of where they live.

Embed appropriate participant and carer support throughout the trial journey, improving participant and carer experience and increasing retention.

Widen access to larger, more diverse populations; broadening diversity among those recruited into dementia trials.

Bring together the UK clinical trials ecosystem and industry partners to help industry partners navigate the UK trials landscape, strengthen the UK trials infrastructure, and accelerate the development of new dementia treatments.

• Streamline trial feasibility, set-up and regulatory processes across the network.

• Establish education and training pathways for dementia research leaders of the future.

Alzheimer’s Society

At Alzheimer’s Society we’re working towards a world where dementia no longer devastates lives. We do this by giving help to those living with dementia today and providing hope for the future. Alzheimer’s Society has invested £3m to develop the first dedicated dementia research nurse programme working across all 4 nations of the UK. Integrated within the UK Dementia Trials Network, the Alzheimer’s Society Research Nurse Programme will fund, develop and support a network of dedicated dementia research nurses to expand capacity and capability in delivering innovative early phase dementia clinical trials across the UK.

CLINICAL RESPONSIBILITIES

Clinical research delivery

As the Alzheimer’s Society UKDTN Research Nurse, you will play a key role in the provision of effective nursing services for optimal early phase trial delivery. You will be responsible for providing clinical and administrative support as Study Coordinator on trials and will be closely involved from clinical start-up at the Site Initiation Visit right through to close-out. You will work closely with the Principal Investigator and collaboratively with the wider study team to ensure high quality research delivery, ensuring participants and their study partners are supported throughout.

Hours of work are normally 9.00am – 5.00pm, with 30 minutes lunch, but some flexibility is required. Occasional out of hours or overnight work may be necessary, for example, if related to a particular research project.

Key Responsibilities

Ensure the smooth delivery of early phase dementia clinical trials by effectively coordinating and delivering participant study visits in line with all applicable research governance requirements, regulations and legislation.

Promote safety and study integrity through monitoring of participants during study procedures and accurate recording of any adverse events and concomitant medications.

• Immediately report, using the appropriate procedures, Serious Adverse Events (SAEs) and Suspected Unexpected Serious Adverse Reactions (SUSARs).

• Collaborate with sponsors to ensure day‑to‑day study operations and support effective monitoring visits.

• Improve recruitment and retention by actively supporting participant engagement with a particular focus on underserved communities.

Maintain high‑quality research data through accurate collection, documentation, and medication accountability.

• Sample processing including preparing, centrifuging, and coordinating transport and storage of blood and biological specimens.

• Accurate recording of electrocardiograms and patient observations/vital signs.

• Liaise with laboratories and radiology departments to ensure appropriate investigations are scheduled and conducted per protocol.

• Support study set-up and delivery by ensuring all research equipment and supplies are

available, maintained, and appropriately calibrated.

• Ensure safe and compliant medication administration under medical direction.

Represent the study site professionally by attending site initiation and investigator meetings, including international meetings when required.

Co-ordinate and manage research within expected timelines and to meet recruitment targets agreed with Investigators, UKDTN and Alzheimer’s Society.

Collaborate with Alzheimer’s Society, UKDTN sites, community groups, local Trusts and regional memory and mental health services to strengthen referral pathways and improve access to early phase dementia clinical research for example being point of contact for referrals.

Compile and contribute to ReMind UK early phase dementia and mild cognitive impairment research activity reports (such as milestone reports for Alzheimer’s Society and UKDTN)

Work in line with UKDTN and Alzheimer’s Society objectives to support delivery of strategic key performance indicators

Maintain UKDTN live capacity and capability database for ReMind UK.

Professional & educational responsibilities:

Ensure safe, lawful, and high‑quality practice by adhering to all legal and statutory regulations, including maintaining regular professional revalidation.

• Safeguard patient rights and dignity by consistently applying Mental Health legislation and ensuring all care respects individual legal entitlements.

Maintain high professional standards by upholding the Nursing and Midwifery Council’s code of conduct in all aspects of practice.

Support consistent, high‑quality service delivery by following ReMind UK policies and SOPs, and contributing to their ongoing review and improvement.

• Enable participant and carer understanding through clear, accessible information about conditions, treatment options, and potential benefits.

• Promote ReMind UK, Alzheimer’s Society and UKDTN reputation and influence by professionally representing the organisation(s) at external functions.

Responsible for developing and sustaining clinical and research knowledge and skills through ongoing personal development and engagement with relevant training opportunities.

• Support developing the workforce by sharing expertise and contributing to the training of multidisciplinary staff.

Required skills

Patient Care

• Demonstrate effective nursing practice in all registered nurse procedures

Proven empathetic and caring approach to patients and relatives, and assured patient confidentiality, dignity and respect at all times

• Ability to prioritise own busy workload and to work under own initiative within boundaries

• Demonstrated awareness and importance of flexibility and working as part of a team

Professional Development

• Commitment to professional development

• Ability to help educate and train others

Communication

• Strong verbal and written communication across different audiences, e.g. staff, patients and relatives

• Excellent ability to accurately and clearly document results, observations, decisions and actions with attention to detail

Good basic IT skills

• Excellent communication and language skills and the ability to promote a cause/product and organisation.

You’ll also be able to demonstrate the following skills:

Qualifications and Experience

• Registered Adult or Mental Health Nurse with at least 2-3 years post registration experience

• Understanding of NMC Code of Practice and up-to-date knowledge of nursing theory and best practice and its application to own practice and behaviour

• Experience in clinical trials and academic research

• Qualified to carry out venepuncture, or willingness to develop competency in this skill

• Qualified to cannulate and administer intravenous fluids and medications, or willingness to develop competency in this skill

Desirable

• Experience in neurology, old-age psychiatry or research delivery in an early phase environment

• Experience of working with people with dementia and with patients in the older age group

• Experience in carrying out cognitive testing and related assessments

• Up-to-date Good Clinical Practice training

• A current driving license and the availability of a car insured for business use

Closing Date and Interviews

Closing date for applications: 21st May 2026

Interview date: 29th May 2026

Applications

Please complete the application form and send to Alison Easto, HR & Operations Manager, alison.easto@reminduk.org

Please note applicants will only be contacted if they have been shortlisted for an interview.